Skip to main content

Alexion.US

This site is intended for US audiences. If you are in another region, please visit our global site to learn more or be directed to your local country page.

Neurofibromatosis type 1 (NF1) plexiform neurofibromas (PN)

What is NF1 PN?

NF1 is a rare, progressive and genetic condition that involves the development of non-malignant (non-cancerous) tumors that may affect the brain, spinal cord and nerves. Initial signs of NF1 may include ‘café au lait’ spots (flat, light brown spots on the skin) and neurofibromas (soft lumps on and under the skin).1-2

Up to 50% of children with NF1 will develop non-malignant tumors on the nerve sheaths called plexiform neurofibromas (PN). PN can appear anywhere inside or outside of the body. They are often identified in infancy or childhood but may also appear later in a person’s life.3-5

Symptoms

PN can cause a range of problems depending on where they are in the body, including:8-10

Pain

Disfigurement

Muscle weakness

Numbness

Numbness

Breathing problems

Bladder or bowel problems

Visual impairment

References

  1. Tamura R. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis. Int J Mol Sci. 2021;22:5850.
  2. Ly K, et al. The diagnosis and management of neurofibromatosis type 1. Med Clin North Am. 2019;103(6):1035-1054.
  3. Miller DT, et al. Health supervision for children with neurofibromatosis type 1. American Academy of Pediatrics. 2019;143(5).
  4. Hirbe AC, et al. Neurofibromatosis type 1: a multidisciplinary approach to care. The Lancet Neurology. 2014;13(8):834-843.
  5. Abdelmoughit E, et al. Plexiform neurofibroma of the thigh: management experience and review of literature. J Pioneer Med Sci. 2015;5:103–106.
  6. Knight SWE, et al. Malignant peripheral nerve sheath tumors – a comprehensive review of pathophysiology, diagnosis, and multidisciplinary management. Children. 2022;9(38):1-14.
  7. Bergqvist C, et al. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis. 2020;15(1):37.
  8. Fisher JM, et al. Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro Oncol. 2022;24(11):1827-1844.
  9. Bajaj, A. The neural pleonastics – neurofibroma. Journal of Clinical and Medical Images. 2020;5(4);1-6.
  10. Georgios T, et al. A review neurofibromatosis type 1: quality of life in children and adolescents. International Journal of Health Sciences. 2024;8(2):194-210.

Veeva ID: US/UNB-NF1/0228